Clinical trials
Coagulation clinical trials
Below are recruiting coagulation clinical trials, each written for real people, not researchers. We’re tracking 61 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05667805RecruitingPhase 4
Testing blood clotting in people with liver cirrhosis
This Phase 4 study looks at how clotting measurements relate to bleeding risk in people with liver cirrhosis who need a planned liver procedure. The study may help doctors understand what coagulation results mean when doing these procedures safely.
ViennaAges 18 years+ - NCT07416526RecruitingPhase 3
Testing NXT007 for hemophilia A without inhibitors
This study tests a new medicine called NXT007 for people with hemophilia A. It compares NXT007 to standard factor VIII treatment to see if it works better at preventing bleeding episodes.
Aurora, ColoradoAges 12 years+ - NCT07418099Recruiting
Study on a blood test for prolonged clotting time
This study looks at a special blood test (clot waveform analysis) to see if it can help doctors better understand why some people have a prolonged clotting time. This might help them find the cause more quickly and accurately.
Leganés, MadridAges Any age - NCT06641375Recruiting
Heat treatment for chronic acid reflux (AREA study)
This trial tests a new way to treat GERD (chronic acid reflux) using a tiny camera and a device that delivers a gentle heat treatment (argon plasma coagulation) to the area where the stomach meets the esophagus. It's compared to a 'sham' procedure (you won't know which you get) to see if it stops acid from backing up better than medicine alone.
Hyderabad, TelanganaAges 18–70 - NCT07384013Recruiting
Metamizole & blood thinners in cancer patients
This study is checking if metamizole (a common painkiller) changes how well the blood thinners apixaban or rivaroxaban work in cancer patients. It aims to help doctors safely use both medicines together for pain and blood clot prevention.
HaifaAges 18 years+ - NCT07376837Recruiting
Radiofrequency ablation for small low-risk thyroid cancer
This study tests whether radiofrequency ablation (a heat-based treatment applied through the skin) can safely and effectively cure small, low-risk papillary thyroid cancers. It is designed for people whose tumors are small, have not spread, and who either cannot have surgery or prefer not to.
Toronto, OntarioAges 18 years+ - NCT07329036Recruiting
Liver support therapy for acute liver failure
This trial tests two different blood-filtering treatments for people with severe liver failure who are waiting for or unable to receive a liver transplant. It aims to see how these treatments affect blood clotting, inflammation, and organ function.
PragueAges 18–75 - NCT04524637Recruiting
Testing a clotting test in recent traumatic brain injury
This trial tests whether a special blood clotting test called thromboelastography can help assess clotting problems after a head injury. It may help doctors better understand bleeding risk and related complications early after trauma.
ShanghaiAges 18–80 - NCT07288489RecruitingPhase 3
A study on VMX-C001 for urgent surgery while on blood thinners
This trial tests a drug called VMX-C001 to quickly reverse the effects of certain blood thinners (Factor Xa inhibitors) in people who need urgent surgery with a high risk of bleeding. It compares VMX-C001 to standard care to see which is more effective at helping blood clot normally.
Chandler, ArizonaAges 18 years+ - NCT07164300Recruiting
Tranexamic acid dosing study in heart surgery
This study compares different doses of tranexamic acid, a medicine that reduces bleeding, in patients having planned heart surgery with a heart-lung machine. It aims to find the best dose to prevent blood loss.
IoanninaAges 18–99 - NCT07152132Recruiting
Comparing two glaucoma surgeries for people who had cataract surgery
This trial studies a new tube-shunt surgery (SCTSC) against the standard trabeculectomy for people with open-angle glaucoma that is not controlled by eye drops. It is only for people who have already had cataract surgery.
MinyaAges 40 years+ - NCT03255928Recruiting
Study blood clot cell activity in people with a heart pump
This study looks at how your blood’s clot-forming cells (platelets) behave when you have a heart pump device placed (short-term or long-term). The results may help doctors better understand complications and how to manage them after implantation.
Milan, MIAges 18–75 - NCT07071051Recruiting
Study of calaspargase pegol on blood clotting in pediatric leukemia
This study looks at how a chemotherapy drug called calaspargase pegol affects blood clotting in children and young adults with leukemia. It will help doctors understand if changes in clotting are common and safe.
Rochester, MinnesotaAges 2–22 - NCT04377490Recruiting
Study of blood clots in hospitalized COVID-19 patients
This study looks at how often blood clot–related problems happen in people hospitalized with serious COVID-19 lung illness. It may help doctors understand risks and improve care for patients in the hospital.
AmiensAges 18 years+ - NCT07024160RecruitingPhase 1
First-in-human study of MT1011 injection in healthy volunteers
This trial tests a new medicine called MT1011 given as an injection. Researchers want to see how safe it is and how the body handles it. Healthy people can join to help find the right dose for future studies.
Beijing, Beijing MunicipalityAges 18–45 - NCT07012291Recruiting
Blood test for patients on blood thinners
This study tests a new blood test called ClotChek™ to see how well it works for people taking direct oral anticoagulants (DOACs), a type of blood thinner. You would give a blood sample, and the test may help doctors better monitor your medication.
Danbury, ConnecticutAges 18–80 - NCT06897904Recruiting
Blood and clotting tests in type 1 diabetes kids
This study looks at blood cell counts and clotting function in children with type 1 diabetes. It aims to find any changes that might be related to diabetes, which could help with better monitoring and care.
Asyut, Asyut GovernorateAges Up to 18 years - NCT06403163Recruiting
Transfusion monitoring during anesthesia
This trial looks at patients who received a drug or product to help with bleeding (hemostasis) during anesthesia. It aims to understand how these products are used and if they are safe.
AnderlechtAges Any age - NCT06476145Recruiting
Testing two ways to reduce polyp regrowth after removal
This study looks at two different methods for removing large colon polyps to see which one better prevents polyps from coming back. It may help people who have a non-cancerous, flat polyp that is at least 20 mm wide.
Orlando, FloridaAges 18 years+ - NCT06410443Recruiting
Steroid treatment for radiation-induced bowel injury
This trial tests if local steroids can help heal bowel damage caused by radiation therapy for cancer. It may reduce pain, bleeding, and urgency, and improve quality of life.
Shenyang, LiaoningAges 18 years+ - NCT06379789RecruitingPhase 1/Phase 2
Gene therapy for severe hemophilia B
This trial tests a new gene therapy (REGV131-LNP1265) that aims to let your body produce its own factor IX, reducing or stopping the need for regular infusions. It is for children and adults with severe hemophilia B who are already using factor IX replacement therapy.
Phoenix, ArizonaAges 2 years+ - NCT06205095RecruitingPhase 3
Wilate for heavy menstrual bleeding in von Willebrand disease
This trial tests whether a medicine called Wilate, given regularly (prophylaxis), can reduce heavy menstrual bleeding in women with von Willebrand disease. It compares Wilate to a placebo (a dummy treatment) to see if it helps more than no treatment.
Kingston, OntarioAges 18 years+ - NCT06165510Recruiting
Convergent ablation and left atrial appendage isolation for persistent AF
This trial tests a two-step procedure for persistent atrial fibrillation that combines a heart ablation with isolation of a small heart pouch. It aims to see if this approach is more effective than standard care.
LondonAges 18–80 - NCT05907629Recruiting
MRI study comparing blood thinners after a certain stroke
This trial looks at MRI scans to compare two types of blood-thinning medicines (one that affects blood-clotting and one that affects platelets) after a recent stroke caused by severe narrowing in certain brain arteries. It may help doctors understand which treatment works best while checking how the blood vessels and brain tissue look on MRI.
Birmingham, AlabamaAges 18 years+
Hear when a new Coagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for coagulation?
- Yes. Clin2 currently lists 61 recruiting coagulation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a coagulation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a coagulation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.